Printer Friendly

Articles from BIOTECH Patent News (October 1, 2003)

1-33 out of 33 article(s)
Title Author Type Words
Abgenix and Amgen clarify responsibilities for epidermal growth factor receptor antibody agreement. 419
Affymetrix and bioMerieux expand infectious disease collaboration. 463
Aventis obtains United States patent. Brief Article 100
Bayer CropScience and Monsanto reach agreement providing farmers with greater access to agricultural technologies. 362
Benitec achieves breakthrough in gene silencing. 624
Bolder BioTechnology receives United States patent for modified human growth hormone. Brief Article 268
Chiron announces settlement of patent dispute over tobramycin solution. 678
Chiron grants non-exclusive HCV license to Pfizer. 329
Dana-Farber, Phosphoproteomics, Cell Signaling Technology agree on phospho-peptide specific antibody technology. Brief Article 243
diaDexus forms diagnostic license agreements with Human Genome Sciences. Brief Article 218
Diversa obtains United States patent. Brief Article 182
European Patent Office affirms revocation of Serono gene. 291
HSP Research Institute obtains United States patent. Brief Article 201
Hybridon obtains patent for second generation antisense oligonucleotides. 332
Immune Response licenses Hybridon's AMPLIVAX vaccine adjuvant. 656
Max-Planck obtains United States patent. Brief Article 190
Merck obtains United States patent. Brief Article 154
Micro Therapeutics announces Dutch Court patent decision. Brief Article 259
Nanogen licenses rights to gene linked to hereditary deafness. 638
Paradigm Genetics and Affymetrix sign microarray technology agreements. 490
Paradigm Genetics receives patent for fungicide target. 348
Patent awarded for pancreatic enzyme therapy for ADD. 363
Pharmacopeia forms drug screening collaboration. 382
Plant Bioscience obtains United States patent. Brief Article 129
Primagen and Delphic form toxicity assay distribution and licensing agreement. 455
Progen granted anti-angiogenesis antibody patent. 415
ProteoTech obtains patent covering treatments for human amyloid diseases. 336
Rib-X Pharmaceuticals receives patent for bacteria technology. 390
Ribonomics obtains United States patent covering methods for obtaining genetic information. 369
Salk Institute obtains United States patent. Brief Article 97
Toyo Boseki obtains United States patent. Brief Article 153
University of Tennessee obtains United States patent. Brief Article 84
VaxGen finalizes commercial rights to anthrax vaccine. 406

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters